{"id":"W2164218337","doi":"10.1111/j.1365-4632.2006.02777.x","title":"Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial","year":2006,"lang":"en","type":"article","venue":"International Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":72,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Western University","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Placebo; Adverse effect; Psoriasis Area and Severity Index; Tolerability; Internal medicine; Randomized controlled trial; Incidence (geometry); Dermatology; Gastroenterology; Plaque psoriasis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00360431,0.001363299,0.003020045,0.000346335,0.0005235007,0.001128899,0.0009495319,0.002694802,0.006351495],"category_scores_gemma":[0.002861452,0.0005535906,0.001600605,0.0005471386,0.001018106,0.0008036814,0.0002791793,0.00219334,0.001013303],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005803533,"about_ca_system_score_gemma":0.001385798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007034862,"about_ca_topic_score_gemma":0.00127404,"domain_scores_codex":[0.998916,0.0005997285,0.00009770405,0.0001785127,0.0000965212,0.0001115297],"domain_scores_gemma":[0.9985905,0.0003997865,0.0004418687,0.00008890239,0.0001387154,0.0003401454],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9705275,0.00419384,0.00105501,0.001318276,0.001095291,0.00005065207,0.00004725049,0.000177107,0.001901571,0.00009992775,0.001580292,0.01795332],"study_design_scores_gemma":[0.9828504,0.01454975,0.001300933,0.00005322359,0.000274829,0.00003279751,0.000007699996,0.000129207,0.0001251143,0.00005297818,0.0006181371,0.000004776078],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9316583,0.04180857,0.002060506,0.002970214,0.001300022,0.01192668,0.002784071,0.0003333793,0.005158242],"genre_scores_gemma":[0.9549032,0.01507339,0.003667805,0.004371625,0.001186175,0.01532645,0.002564593,0.0000457226,0.002861085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006351495,"threshold_uncertainty_score":0.02124786,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005841247212327164,"score_gpt":0.2477596451481913,"score_spread":0.2419183979358641,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}